ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 254 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2022. The put-call ratio across all filers is 8.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,423,515 | -1.4% | 564,955 | -5.5% | 0.00% | 0.0% |
| Q2 2023 | $7,528,911 | +2.6% | 597,533 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $7,341,326 | +3.9% | 562,553 | +40.4% | 0.00% | 0.0% |
| Q4 2022 | $7,068,842 | -3.9% | 400,728 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $7,353,000 | +3.1% | 482,798 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $7,135,000 | -26.9% | 481,083 | +11.0% | 0.00% | -33.3% |
| Q1 2022 | $9,758,000 | -11.5% | 433,287 | -27.5% | 0.00% | 0.0% |
| Q4 2021 | $11,030,000 | +23.4% | 597,836 | -10.6% | 0.00% | +50.0% |
| Q3 2021 | $8,937,000 | +73.8% | 668,531 | +140.7% | 0.00% | +100.0% |
| Q2 2021 | $5,142,000 | -55.4% | 277,785 | -63.9% | 0.00% | -66.7% |
| Q1 2021 | $11,541,000 | +43.2% | 768,644 | +37.8% | 0.00% | +50.0% |
| Q4 2020 | $8,057,000 | +1.1% | 557,938 | -43.0% | 0.00% | 0.0% |
| Q3 2020 | $7,970,000 | +42.6% | 979,074 | +18.6% | 0.00% | 0.0% |
| Q2 2020 | $5,589,000 | -15.9% | 825,486 | -12.5% | 0.00% | 0.0% |
| Q1 2020 | $6,643,000 | +17.3% | 943,557 | +63.5% | 0.00% | 0.0% |
| Q4 2019 | $5,664,000 | +23.3% | 577,073 | +38.0% | 0.00% | +100.0% |
| Q3 2019 | $4,593,000 | -2.5% | 418,316 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $4,713,000 | -51.3% | 405,274 | -60.1% | 0.00% | -66.7% |
| Q1 2019 | $9,681,000 | -0.9% | 1,014,817 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $9,772,000 | -39.0% | 1,013,684 | -9.8% | 0.00% | -40.0% |
| Q3 2018 | $16,016,000 | +15.7% | 1,123,910 | -2.6% | 0.01% | +25.0% |
| Q2 2018 | $13,840,000 | -2.9% | 1,153,344 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $14,258,000 | -17.4% | 1,154,525 | -2.7% | 0.00% | -20.0% |
| Q4 2017 | $17,267,000 | +34.1% | 1,186,839 | +31.2% | 0.01% | +25.0% |
| Q3 2017 | $12,876,000 | -2.5% | 904,873 | -12.6% | 0.00% | 0.0% |
| Q2 2017 | $13,210,000 | +2.0% | 1,035,094 | +1.4% | 0.00% | 0.0% |
| Q1 2017 | $12,948,000 | -42.3% | 1,021,135 | -53.5% | 0.00% | -50.0% |
| Q4 2016 | $22,439,000 | +164.6% | 2,197,788 | +241.3% | 0.01% | +166.7% |
| Q3 2016 | $8,481,000 | -7.0% | 643,999 | -10.3% | 0.00% | -25.0% |
| Q2 2016 | $9,119,000 | -10.7% | 717,991 | -7.1% | 0.00% | 0.0% |
| Q1 2016 | $10,213,000 | -12.0% | 773,082 | +2.4% | 0.00% | -20.0% |
| Q4 2015 | $11,607,000 | +4.6% | 754,706 | -15.7% | 0.01% | 0.0% |
| Q3 2015 | $11,096,000 | -29.9% | 894,851 | -22.7% | 0.01% | -16.7% |
| Q2 2015 | $15,823,000 | -44.2% | 1,157,552 | -51.2% | 0.01% | 0.0% |
| Q1 2015 | $28,380,000 | +83.4% | 2,372,980 | +95.8% | 0.01% | 0.0% |
| Q4 2014 | $15,475,000 | -0.1% | 1,211,825 | +4.9% | 0.01% | 0.0% |
| Q3 2014 | $15,495,000 | -25.0% | 1,155,083 | -10.2% | 0.01% | -33.3% |
| Q2 2014 | $20,647,000 | -15.8% | 1,286,334 | -5.4% | 0.01% | -10.0% |
| Q1 2014 | $24,518,000 | -10.9% | 1,359,940 | -23.6% | 0.01% | -16.7% |
| Q4 2013 | $27,519,000 | +3.2% | 1,780,051 | -0.8% | 0.01% | -7.7% |
| Q3 2013 | $26,672,000 | +17.2% | 1,793,642 | +2.0% | 0.01% | +8.3% |
| Q2 2013 | $22,759,000 | – | 1,758,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |